Related Experiment Video
Updated: Sep 15, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Targeting androgen receptor stability and degradation: approaches for developing a therapy for spinal and bulbar
Riccardo Cristofani1, Barbara Tedesco2, Veronica Ferrari2
1Dipartimento di Scienze Farmacologiche e Biomolecolari "Rodolfo Paoletti", Dipartimento di Eccellenza (2018-2027), Università degli Studi di Milano, Milan, 20133, Italy. riccardo.cristofani@unimi.it.
Abstract:
Conformational changes of proteins can occur due to mutations or stress conditions, altering their functionality through loss of physiological or gain of pathological function. A Protein Quality Control (PQC) system exists in cells to deal with the accumulation of misfolded proteins and aggregates, comprising a network of chaperones and degradative pathways to refold or remove the aberrant proteins. Protein misfolding and PQC system impairment lead to a broad range of diseases, including neurodegenerative and neuromuscular disorders, among them spinal and bulbar muscular atrophy (SBMA). SBMA is a neuromuscular disorder caused by a polyglutamine expansion (polyQ) in the androgen receptor (AR) protein. Expanded AR (ARexp) is highly prone to misfolding and aggregation, leading to its accumulation in affected tissues. Here, we summarise the dynamics that control AR protein stability and its degradation in physiological conditions. Next, we recapitulate the current knowledge of the molecular mechanisms of SBMA pathogenesis involving the PQC system. Finally, we provide an overview of promising approaches to SBMA intervention involving the modulation of PQC system functions to reduce ARexp accumulation and its toxic effects in affected cells.
Insights
Protein misfolding and impaired quality control cause diseases like spinal and bulbar muscular atrophy (SBMA). Targeting the protein quality control system may offer new treatments for SBMA by reducing toxic protein accumulation.
Area of Science:
- Molecular biology
- Cellular biology
- Neuroscience
Background:
- Protein misfolding and aggregation are implicated in various diseases.
- The cellular Protein Quality Control (PQC) system manages misfolded proteins.
- Impairment of the PQC system contributes to neurodegenerative disorders such as spinal and bulbar muscular atrophy (SBMA).
Purpose of the Study:
- To summarize the mechanisms governing androgen receptor (AR) protein stability and degradation.
- To review the role of the PQC system in the pathogenesis of SBMA.
- To explore potential therapeutic strategies for SBMA targeting PQC modulation.
Main Methods:
- Literature review of protein folding dynamics.
- Analysis of PQC system involvement in SBMA.
- Overview of therapeutic interventions for SBMA.
Main Results:
- AR protein stability and degradation are tightly regulated under physiological conditions.
- Misfolded expanded AR (ARexp) accumulates in SBMA due to PQC system dysfunction.
- PQC system modulation presents a promising therapeutic avenue for SBMA.
Conclusions:
- Understanding AR protein dynamics and PQC function is crucial for SBMA research.
- Targeting the PQC system offers a potential strategy to mitigate ARexp toxicity in SBMA.
- Further research into PQC modulation could lead to novel SBMA treatments.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Satellite Stem Cells and Muscular Dystrophy
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment
Targeted Cancer Therapies
There are several types of targeted therapies against...

